Cargando…
Treatment and prognosis of type B2 thymoma
BACKGROUND: Because of the rarity of thymoma, no randomized trials have prospectively detected the prognosis and optimal treatment for type B2 thymoma. The aim of this study is to investigate the treatment and prognosis for patients with type B2 thymoma. METHODS: We retrospectively evaluated the out...
Autores principales: | Song, Zhengbo, Jin, Xiangyu, Zhang, Yiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247722/ https://www.ncbi.nlm.nih.gov/pubmed/25240293 http://dx.doi.org/10.1186/1477-7819-12-291 |
Ejemplares similares
-
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma
por: Zhao, Ke, et al.
Publicado: (2023) -
Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer
por: Song, Zhengbo, et al.
Publicado: (2016) -
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma
por: Hao, Yue, et al.
Publicado: (2022) -
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
por: Hao, Yue, et al.
Publicado: (2022) -
Chemotherapy and prognosis in advanced thymic carcinoma patients
por: Song, Zhengbo, et al.
Publicado: (2015)